A. Rochand

Long‐Term Outcomes in Head and Neck Paragangliomas Managed with Intensity‐Modulated Radiotherapy

P. Maingon, P. Herman, N. Burnichon, 2022, The Laryngoscope.

Human Epidermal Growth Factor Receptor 2 (HER2) in Advanced Gastric Cancer: Current Knowledge and Future Perspectives

J. Taïeb, S. Pernot, A. Zaanan, 2020, Drugs.

Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer.

D. Pinato, B. Besse, B. Routy, 2023, Lung cancer.

Severe sotorasib-related hepatotoxicity and non-liver adverse events associated with sequential anti-PD(L)1 and sotorasib therapy in KRASG12C-mutant lung cancer.

C. Mascaux, E. Wasielewski, V. Gounant, 2023, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[Collecting duct carcinoma and renal medullary carcinoma in the age of new therapies].

Y. Allory, C. Gervais, F. Audenet, 2023, Bulletin du cancer.